CMS published its proposed 2027 outpatient payment rule, including a 2.4% base rate increase alongside steep cuts to 340B drug payments and an expansion of site-neutral payment to off-campus imaging services. Provider groups warn that these changes would push many hospitals' payments into negative territory.
Eli Lilly made good on its threat to withhold 340B drug discounts from hospitals that refused to submit claims data. Hospital groups are calling the policy unlawful, arguing that the company has no legal authority to create its own compliance requirements for a federal program.
We'll explore why the next era of payer performance will depend on building a trusted data foundation that connects people, providers, and relationships across the enterprise.
HHS is scrapping its proposed 340B rebate pilot after hospitals sued to stop it. Providers say the plan would have created cash flow problems and administrative burdens that threatened safety-net care.
December has seen a slew of executive hires, promotions and layoffs across the healthcare industry. For instance, Breyer Capital, the FDA and Strive Health named new executives. There were also layoffs at organizations including Alameda Health System, Pfizer and Voyager Therapeutics.
Employers are advocating for changes to the 340B Drug Pricing Program, arguing that it allows hospitals to "buy low and sell high" by purchasing discounted medications and charging insured patients full price.
If the One Big Beautiful Bill Act is signed into law, it would result in a $50.4 billion reduction in federal Medicaid spending on rural hospitals over the next decade, which could put 338 rural hospitals at risk of closure, according to new analyses.
Discover the top AI-powered EAP providers for 2026. Compare platforms like Kyan Health and Spring Health on triage speed, global reach, and clinical quality to transform workforce wellbeing.
Hospitals' costs are climbing steadily — driven by chronic underpayments from payers, growing administrative requirements and increasing labor costs, according to a new report from the American Hospital Association.
The Trump administration’s steep tariffs on Chinese imports are threatening to further destabilize hospitals’ bottom lines by driving up the cost of essential supplies and exacerbating already fragile supply chains. As providers prepare for higher expenses and potential shortages, experts warn that these policies could worsen care quality and force hospitals to make tough financial decisions — from cutting services to delaying tech upgrades.
House Republicans proposed Medicaid cuts last month that would have disastrous financial consequences for hospitals, especially for those in rural areas. While the plan aims to reduce government spending, healthcare executives are pointing out that these cuts would actually exacerbate the financial instability of the overall U.S. healthcare system — as well worsen health outcomes for millions of people, many of whom are children.
Here is a selection of recent executive hires, exits, promotions and layoffs occurring across the healthcare industry.
By reducing administrative burden and redesigning workflows around human needs, it creates space for what matters most: connection between clinicians and patients.
In this month’s episode, Senior Reporter Katie Adams discussed some of the executive moves, exits and layoffs that occurred recently in the healthcare sector. She also interviewed Claire Zangerle, who was appointed as chief nurse executive of the American Hospital Association, as well as CEO of its American Organization for Nursing Leadership.
Hospitals are facing increasingly burdensome policies from commercial insurers, leading to problems with cash flow and patient safety. Hospital executives think federal regulators need to enact stricter policies that require payers to operate on faster timelines, as well as provide more transparency into their reasons for denying claims.
Here is a selection of recent executive hires, retirements, promotions and layoffs occurring across the healthcare industry.
Johnson & Johnson announced last week a major change in the way it offers 340B pricing for two medications. The change is "inconsistent" with the 340B statute, according to HRSA.
CMS finalized a rule this week that will boost hospitals’ inpatient payment rates by 2.9%. Hospitals groups are unhappy with this payment update, arguing that it is insufficient and will exacerbate hospitals’ financial challenges.